Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery
Conditions: Sellar and Suprasellar Masses; Pituitary Tumor Intervention: Sponsor: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2020 Category: Research Source Type: clinical trials
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study
Conditions: Diabetes Insipidus; Polydipsia, Primary Interventions: Diagnostic Test: Arginine infusion; Diagnostic Test: Hypertonic saline infusion Sponsors: University Hospital, Basel, Switzerland; Kantonsspital Aarau; Luzerner Kantonsspital; Kantonsspital St. Gallen, Switzerland; University Hospital, Zürich; Wuerzburg University Hospital; University Hospital Lübeck; Federal University of Minas Gerais Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2018 Category: Research Source Type: clinical trials